61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
61%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
61%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Aurinia Pharmaceuticals Inc
Closed
Sector Healthcare
8.26 3.25
Overview
Share price change
24h
Min
7.95
Max
8.27
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +28.5 upside |
Next Earnings | 13 Feb 2025 |
|---|
News Sentiment
By Acuity
50%
50%
156 / 393 Healthcare
Technical Score
By Trading Central
Confidence
Bearish Evidence
Aurinia Pharmaceuticals Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Aurinia Pharmaceuticals Inc Forecast
Price Target
By TipRanks
28.5% upside
12 Months Forecast
Average 10.28 USD 28.5%
High 11 USD
Low 9 USD
Based on 4 Wall Street analysts offering 12 month price targets forAurinia Pharmaceuticals Inc - Dist in the last 3 months.
Sentiment
By Acuity
156 / 393 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
$
